These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34400299)

  • 1. Discovery and evaluation of non-basic small molecule modulators of the atypical chemokine receptor CXCR7.
    Aspnes GE; Menhaji-Klotz E; Boehm M; Londregan AT; Lee ECY; Limberakis C; Coffey SB; Brown JA; Jones RM; Hesp KD
    Bioorg Med Chem Lett; 2021 Oct; 50():128320. PubMed ID: 34400299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis.
    Menhaji-Klotz E; Hesp KD; Londregan AT; Kalgutkar AS; Piotrowski DW; Boehm M; Song K; Ryder T; Beaumont K; Jones RM; Atkinson K; Brown JA; Litchfield J; Xiao J; Canterbury DP; Burford K; Thuma BA; Limberakis C; Jiao W; Bagley SW; Agarwal S; Crowell D; Pazdziorko S; Ward J; Price DA; Clerin V
    J Med Chem; 2018 Apr; 61(8):3685-3696. PubMed ID: 29627981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.
    Hunger C; Ödemis V; Engele J
    Exp Cell Res; 2012 Oct; 318(17):2178-90. PubMed ID: 22766125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists.
    Wijtmans M; Maussang D; Sirci F; Scholten DJ; Canals M; Mujić-Delić A; Chong M; Chatalic KL; Custers H; Janssen E; de Graaf C; Smit MJ; de Esch IJ; Leurs R
    Eur J Med Chem; 2012 May; 51():184-92. PubMed ID: 22424612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.
    Ngamsri KC; Jans C; Putri RA; Schindler K; Gamper-Tsigaras J; Eggstein C; Köhler D; Konrad FM
    Front Immunol; 2020; 11():407. PubMed ID: 32210974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulators of CXCR4 and CXCR7/ACKR3 Function.
    Adlere I; Caspar B; Arimont M; Dekkers S; Visser K; Stuijt J; de Graaf C; Stocks M; Kellam B; Briddon S; Wijtmans M; de Esch I; Hill S; Leurs R
    Mol Pharmacol; 2019 Dec; 96(6):737-752. PubMed ID: 31548340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.
    Rafiei S; Gui B; Wu J; Liu XS; Kibel AS; Jia L
    Mol Cancer Res; 2019 Jan; 17(1):263-276. PubMed ID: 30224544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A
    Konrad FM; Meichssner N; Bury A; Ngamsri KC; Reutershan J
    Cell Death Dis; 2017 May; 8(5):e2832. PubMed ID: 28542132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
    Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
    Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239.
    Richard-Bildstein S; Aissaoui H; Pothier J; Schäfer G; Gnerre C; Lindenberg E; Lehembre F; Pouzol L; Guerry P
    J Med Chem; 2020 Dec; 63(24):15864-15882. PubMed ID: 33314938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDF-1α induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival.
    Chatterjee M; Seizer P; Borst O; Schönberger T; Mack A; Geisler T; Langer HF; May AE; Vogel S; Lang F; Gawaz M
    FASEB J; 2014 Jul; 28(7):2864-78. PubMed ID: 24668750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Regulatory B-Cells by Mesenchymal Stem Cells is Affected by SDF-1α-CXCR7.
    Qin Y; Zhou Z; Zhang F; Wang Y; Shen B; Liu Y; Guo Y; Fan Y; Qiu J
    Cell Physiol Biochem; 2015; 37(1):117-30. PubMed ID: 26303308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
    Burns JM; Summers BC; Wang Y; Melikian A; Berahovich R; Miao Z; Penfold ME; Sunshine MJ; Littman DR; Kuo CJ; Wei K; McMaster BE; Wright K; Howard MC; Schall TJ
    J Exp Med; 2006 Sep; 203(9):2201-13. PubMed ID: 16940167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
    Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
    J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
    Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
    J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.
    Boehm M; Beaumont K; Jones R; Kalgutkar AS; Zhang L; Atkinson K; Bai G; Brown JA; Eng H; Goetz GH; Holder BR; Khunte B; Lazzaro S; Limberakis C; Ryu S; Shapiro MJ; Tylaska L; Yan J; Turner R; Leung SSF; Ramaseshan M; Price DA; Liras S; Jacobson MP; Earp DJ; Lokey RS; Mathiowetz AM; Menhaji-Klotz E
    J Med Chem; 2017 Dec; 60(23):9653-9663. PubMed ID: 29045152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
    Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
    Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells.
    Dai X; Tan Y; Cai S; Xiong X; Wang L; Ye Q; Yan X; Ma K; Cai L
    J Cell Mol Med; 2011 Jun; 15(6):1299-309. PubMed ID: 21418513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3).
    Sekiguchi H; Kuroyanagi T; Rhainds D; Kobayashi K; Kobayashi Y; Ohno H; Heveker N; Akaji K; Fujii N; Oishi S
    J Med Chem; 2018 Apr; 61(8):3745-3751. PubMed ID: 29608300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.